| Identification of the region 285–309 of follicle stimulating hormone receptor as a bioneutralizing epitope JD Ghosalkar, SJ Dharma, TD Nandedkar, SD Mahale Journal of reproductive immunology 74 (1-2), 24-33, 2007 | 13 | 2007 |
| Characterization of peptide 20–30 of follicle stimulating hormone receptor as an antagonist of receptor activity: significance of charged residues M Dupakuntla, JD Ghosalkar, SD Mahale Chemical biology & drug design 73 (1), 108-114, 2009 | 8 | 2009 |
| Prostate apoptosis response-4 (Par-4): a novel target in pyronaridine-induced apoptosis in glioblastoma (GBM) cells J Ghosalkar, V Sonawane, T Pisal, S Achrekar, R Pujari, A Chugh, ... Cancers 14 (13), 3198, 2022 | 6 | 2022 |
| Detailed analysis of the region 9–30 of rat follicle stimulating hormone receptor: Identification of peptide 20–30 as a potential hormone binding inhibitor JD Ghosalkar, SD Mahale Peptides 27 (11), 2894-2900, 2006 | 6 | 2006 |
| Ketorolac modulates Rac-1/HIF-1α/DDX3/β-catenin signalling via a tumor suppressor prostate apoptosis response-4 (Par-4) in renal cell carcinoma V Sonawane, J Ghosalkar, S Achrekar, K Joshi Scientific Reports 13 (1), 5659, 2023 | 4 | 2023 |
| In vitro and in vivo anticancer potential of adapalene, a third-generation retinoid against bladder cancer J Ghosalkar, S Iyer, G Malhotra, K Joshi Cancer Research 78 (13_Supplement), 2316-2316, 2018 | 4 | 2018 |
| Mesalamine for the treatment of cancer G Malhotra, K Joshi, J Ghosalkar US Patent 9,867,865, 2018 | 3 | 2018 |
| Pharmaceutical Formulations G Malhotra, K Joshi, P Raut, J Ghosalkar, N Dixit US Patent App. 17/048,303, 2021 | 2 | 2021 |
| A carbonic anhydrase inhibitor methazolamide potentiates efficacy of gemcitabine by modulating anti-proliferative activity and cancer stem cell markers in pancreatic carcinoma K Joshi, JD Ghosalkar, VR Sonawane, SR Raut, G Malhotra Cancer Research 79 (13_Supplement), 2013-2013, 2019 | 2 | 2019 |
| Thienopyridine derivative for the treatment of hepatitis C infections K Roberts, G Malhotra, D Abhyankar, K Joshi, J Ghosalkar US Patent 9,937,160, 2018 | 2 | 2018 |
| Pharmaceutical compositions comprising rifaximin G Malhotra, K Joshi, J Ghosalkar US Patent 11,224,591, 2022 | 1 | 2022 |
| Prostate apoptosis response-4: A therapeutic target for malignant gliomas J Ghosalkar, V Sonawane, M Khan, K Joshi, P Shastry Tumor Suppressor Par-4: Role in Cancer and Other Diseases, 77-111, 2021 | 1 | 2021 |
| Thienopyridine derivative for the treatment of hepatitis C infections K Roberts, G Malhotra, D Abhyankar, K Joshi, J Ghosalkar US Patent 10,471,048, 2019 | 1 | 2019 |
| Ketorolac for the Treatment of Cancer G Malhotra, K Joshi, J Ghosalkar US Patent 10,391,080, 2019 | 1 | 2019 |
| Anti-malarial drug Pyronaridine modulates microenvironment leading to potent anti-cancer activity against GBM JD Ghosalkar, VR Sonawane, SR Raut, M Thekkumpurath, R Pujari, ... Cancer Research 79 (13_Supplement), 251-251, 2019 | 1 | 2019 |
| Abstract B141: repurposing of ketorolac for the treatment of renal cell carcinoma (RCC) JD Ghosalkar, SR Raut, MC Thekkumpurath, G Malhotra, KS Joshi Molecular Cancer Therapeutics 17 (1_Supplement), B141-B141, 2018 | 1 | 2018 |
| Par-4 agonists for the treatment of cancer G Malhotra, K Joshi, J Ghosalkar US Patent App. 15/635,507, 2017 | 1 | 2017 |
| Optimization of an in vitro method for assessing pulmonary permeability of inhaled drugs using alveolar epithelial cells N Shirsath, R Chaudhari, A More, V Sonawane, J Ghosalkar, K Joshi Journal of Pharmacological and Toxicological Methods, 107526, 2024 | | 2024 |
| Method of treating hypertension G Malhotra, K Joshi, J Ghosalkar US Patent App. 18/301,643, 2024 | | 2024 |
| Method of Treating Viral Infection K Joshi, J Ghosalkar, D Gaikwad US Patent App. 18/265,131, 2024 | | 2024 |
